Certara

Overview

Certara is a publicly traded biosimulation and drug development services company whose regulatory science business (built on the Synchrogenix consultancy) provides regulatory and medical writing services and AI-enabled writing software such as CoAuthor.

Notable

Synchrogenix acquired ClinGenuity's AI-assisted medical writing capability in 2015; Certara launched CoAuthor generative AI writing tool.

Key services

regulatory writing
medical writing
regulatory submissions
AI-assisted writing software (CoAuthor, Synchrogenix Writer)

Subcategories

Medical Writing
Regulatory Writing
Regulatory Technology
Regulatory Consulting
Regulatory Operations

Verified Reviews

No verified reviews yet — are you a customer of Certara? Share your experience in a short, confidential interview.

Share your experience

Sources

https://ir.certara.com/news-releases/news-release-details/certara-launches-new-synchrogenixtm-writer-software-accelerate
https://www.certara.com/announcement/certara-launches-coauthor-a-regulatory-and-medical-writing-tool/
https://www.biospace.com/b-synchrogenix-b-certara-corporation-s-regulatory-and-medical-writing-consultancy-acquires-b-clingenuity-b
https://www.certara.com